It’s no secret that the US healthcare industry has struggled to keep up with the changing demands of the healthcare market.

But one key factor has been the high cost of medications, especially in the last several years.

In 2014, the average annual cost of a prescription was $14,979.

That rose to $20,821 in 2017, and now is $27,726.

And according to a new report from the nonprofit Center for Responsive Politics, the cost of prescriptions has reached $300 billion per year.

That’s a huge increase over the $250 billion in 2016.

So what’s behind this?

A big part of the reason is that drug prices are set by the government, and in the healthcare industry, drug prices vary greatly from one state to another.

That means if you are in one state and the cost is cheaper than in another, that could mean a different pharmacy is offering the same medication.

So that means you’re paying more to get the same thing at the same price.

This leads to prices that aren’t as affordable in some places as they are in others.

For example, if you have a generic drug in New York and you’re going to be in a rural area, you may have to pay more.

That could be because there is a higher price for the generic in that part of New York.

Another factor that could be at play is the fact that some pharmaceuticals are so expensive, they’re not just a generic but also a brand-name drug, which means that the generic version of the drug has a higher markup.

These high prices are one of the reasons why so many people aren’t able to afford their medications, even if they have the ability to get them from a pharmacy.

In addition to high prices, the rise in drug prices is also a factor in the rising cost of prescription medications.

According to the Center for Data Analysis, prescription prices rose by 6% in 2016, the first year for which data is available.

The reason for that jump is because prescription prices have increased in response to an increase in spending for health insurance.

In 2016, Medicare paid out more than $7 trillion to insurance companies to cover their enrollees, and that amount is expected to increase by another $7.5 trillion in 2020.

That money is supposed to be used to pay for the prescription drug program, but because the insurance companies have increased their payments to cover the cost, the program has been able to increase spending even more.

This means that as the cost for drugs like EpiPens and other prescription drugs has gone up, the prices for other prescription medications have also gone up.

According, the Kaiser Family Foundation: There are more than 700 million people enrolled in Medicaid, or federal health insurance programs, and about 60% of those people receive benefits.

Medicare and the federal health care law, known as the Affordable Care Act, require insurance companies covering Medicare beneficiaries to provide coverage to those people.

Medicaid is a program for low-income people that helps cover their medical costs for the first time.

It is the federal government’s program for health care for people under 65 who are poor or have disabilities.

If the program for Medicaid enrollees is funded at a certain level, they receive Medicaid.

Medicaid pays for most out-of-pocket expenses for people who receive it, and some people who are eligible for Medicaid are eligible to enroll in Medicaid.

In 2018, more than 9 million people signed up for Medicaid, and the number is expected in 2019 to surpass 11 million.

The cost of pharmaceuticals Pharmaceuticals are another major factor contributing to the rising costs of healthcare.

According the Center on Budget and Policy Priorities, pharmaceutical companies spend a lot of money developing new drugs, so when they get them approved by the FDA, the drug is generally cheaper than the original.

That often means that a drug costs less than the cost it would have cost in a market where the drug was less effective.

The amount of money spent on research and development is another way in which the pharmaceutical industry makes money.

In 2017, pharmaceutical research and drug development spending accounted for nearly 7% of the total spending on drugs and health care in the US, up from 3% in 2015.

But even with the rise of the cost and the increased use of prescription drugs, the price of pharmaceutical drugs have not kept pace with the cost.

For the most part, pharmaceuticals do not cost more than other drugs, and there is no reason to think that they will soon.

But there are some things that pharmaceutical companies do have to consider when they are pricing drugs.

One of them is the pricing model, which determines the price a drug will be paid for.

Pharmaceutical companies can charge different prices to different classes of drugs.

For instance, in a class of drugs called pre-clinical studies, the company may charge a price that includes a small upfront investment in a drug and other costs associated with developing it.

For an experimental drug, the